Raymond Omollo Selected Research

Antimony Sodium Gluconate (Sodium, Stibogluconate)

3/2017	Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
1/2016	Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
1/2012	Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
6/2011	Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
11/2010	Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond Omollo Research Topics

Disease

12	Visceral Leishmaniasis (Kala Azar) 01/2019 - 10/2010
1	Sepsis (Septicemia) 01/2022
1	Neonatal Sepsis 01/2022
1	Cicatrix (Scar) 01/2020
1	Buruli Ulcer 01/2020
1	Renal Insufficiency (Renal Failure) 01/2019
1	Malaria 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2015
1	Mental Disorders (Mental Disorder) 10/2015
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2014
1	Body Weight (Weight, Body) 01/2014
1	Coinfection 11/2010

Drug/Important Bio-Agent (IBA)

5	liposomal amphotericin B FDA Link 01/2019 - 03/2011
5	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 03/2017 - 11/2010
4	miltefosine (Impavido)IBA 01/2019 - 06/2011
4	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 03/2017 - 10/2010
2	SodiumIBA 01/2022 - 11/2010
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Fosfomycin FDA Link 01/2022
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	artenimol (dihydroartemisinin)IBA 01/2014
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2014
1	piperaquineIBA 01/2014
1	TabletsIBA 01/2014
1	Meglumine AntimoniateIBA 11/2010
1	AntimonyIBA 11/2010
1	gluconic acid (gluconate)FDA LinkGeneric 11/2010

Therapy/Procedure

1	Therapeutics 01/2020
1	Activities of Daily Living (ADL) 10/2015
1	Duration of Therapy 06/2011